---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-025001"
form_type: "8-K"
ticker: "NEPH"
cik: "0001196298"
company_name: "NEPHROS INC"
filed_at: "2021-10-08T23:59:59+00:00"
generated_at: "2026-06-28T21:45:21.785509+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Nephros prelim Q3 2021 net revenue ~$2.6M (+24% YoY); YTD record $7.6M

## Summary
- Preliminary net revenue ~$2.6M for Q3 2021, up 24% YoY.
- Year-to-date revenue ~$7.6M, highest in company history (+22% vs 2020).
- Third consecutive quarter of ~25% average YoY growth.
- Pathogen Detection Systems segment contributed nearly $60K in Q3 revenue.
- Cash ~$7.3M at quarter end; full results expected Nov 4, 2021.

## SEC filing metadata
- accession: 0001493152-21-025001
- form_type: 8-K
- ticker: NEPH
- cik: 0001196298
- company_name: NEPHROS INC
- filed_at: 2021-10-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1196298/000149315221025001/0001493152-21-025001-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1196298/000149315221025001/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-025001
- JSON: https://secwatch.observer/filing/0001493152-21-025001.json
- Plain text: https://secwatch.observer/filing/0001493152-21-025001.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.